Literature DB >> 7476816

Malignant cerebral edema and intracranial hypertension.

W E Bingaman1, J I Frank.   

Abstract

Cerebral edema and intracranial hypertension occur frequently in neurologic patients. Proper understanding of the pathophysiology of each entity allows prompt recognition and rational therapeutic goals, allowing for better neurologic outcome in many disease states. The recognition of cerebral edema as a distinct entity allows the clinician to treat focal pressure gradients in the brain separately from more diffuse intracranial pressure elevations, appreciating the benefits and pitfalls of directed therapies for each process. The treatment of many of the disorders that cause cerebral edema and intracranial hypertension is heuristic, challenging the managing physician's thorough understanding of cerebral hemodynamics and his or her ability to encounter the human aspects of determining appropriate levels of care for individual patients.

Entities:  

Mesh:

Year:  1995        PMID: 7476816

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  12 in total

1.  Cerebral Edema: Hypertonic Saline Solutions.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  Hypertonic saline for cerebral edema.

Authors:  Alexandros L Georgiadis; José I Suarez
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

3.  Reduction of cerebral edema after traumatic brain injury using an osmotic transport device.

Authors:  Devin W McBride; Jenny I Szu; Chris Hale; Mike S Hsu; Victor G J Rodgers; Devin K Binder
Journal:  J Neurotrauma       Date:  2014-10-14       Impact factor: 5.269

4.  Cerebrospinal fluid drainage and cranial decompression prolong survival in rats with fulminant hepatic failure.

Authors:  Satoshi Yamamoto; Jeffery L Steers; Robert E Wharen; Christopher B Eckman; Justin H Nguyen
Journal:  Transpl Int       Date:  2006-08       Impact factor: 3.782

5.  Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications.

Authors:  D A Stevens; D W Denning; S Shatsky; R W Armstrong; J D Adler; B H Lewis
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 6.  Japanese viral encephalitis.

Authors:  S V Tiroumourougane; P Raghava; S Srinivasan
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

Review 7.  Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management.

Authors:  Olivier Detry; Arnaud De Roover; Pierre Honore; Michel Meurisse
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 8.  Multimodal brain monitoring in fulminant hepatic failure.

Authors:  Fernando Mendes Paschoal; Ricardo Carvalho Nogueira; Karla De Almeida Lins Ronconi; Marcelo de Lima Oliveira; Manoel Jacobsen Teixeira; Edson Bor-Seng-Shu
Journal:  World J Hepatol       Date:  2016-08-08

9.  Raised Intracranial Pressure.

Authors:  Eliahu S Feen; Jose I Suarez
Journal:  Curr Treat Options Neurol       Date:  2005-03       Impact factor: 3.972

10.  Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double-blinded, randomised controlled trial.

Authors:  Qian Li; Han Chen; Jing-Jing Hao; Ning-Ning Yin; Ming Xu; Jian-Xin Zhou
Journal:  BMC Anesthesiol       Date:  2015-10-07       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.